No Data
No Data
BofA Securities Initiates Ginkgo Bioworks(DNA.US) With Sell Rating, Announces Target Price $0.25
BofA Securities analyst Michael Ryskin initiates coverage on $Ginkgo Bioworks(DNA.US)$ with a sell rating, and sets the target price at $0.25.According to TipRanks data, the analyst has a success
Express News | Ginkgo Bioworks Holdings Inc : BofA Global Research Cuts Price Objective to $0.25 From $0.8
Express News | Syngenta Partners With Ginkgo Bioworks To Boost The Launch Of Biologicals
Express News | Syngenta Collaborates With Ginkgo Bioworks to Enable Faster Launch of Innovative Biologicals
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?
Express News | Goldman Sachs Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $0.3
No Data
Rigid Bull : I voted for it. but founders have super voting shares![rolling_on_the_floor_laughing 🤣](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f923.png)